Available Credit
10.00 ACPE Pharmacy
The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 10.00 credit by the Washington State Pharmacy Association.
This activity is approved for up to 10.00 credit by the Washington State Pharmacy Association. ACPE#: 0130-9999-21–L01-P | Activity Type: Live| Start/End date: Fri, 05/05/2023 – 7:00am-Sat, 05/06/2023 – 4:30pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 50 days after the activity – please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171
10.00 AMA PRA Category 1 Credit™
Horizon CME designates this Live activity for a maximum of 10.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
10.00 ANCC
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 10.00 credit.
4.00 Pharmacology
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 4.00 credit.
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Eastern Standard Time Zone
Friday, May 5, 2023 |
7:00am | Check-In & Breakfast Available in Exhibit Hall |
8:00am | Horizon CME APP Overview |
8:05am | Welcome, Introductions, & CE Housekeeping |
8:10am | (01) Thrombotic Microangiopathies: A Deeper Dive Into Effective Management Strategies » Jean Yared, MD – University of Maryland Medical System |
9:10am | (02) Best Practices and the Future of CAR T-Cell Therapy » Mindy Landau, MS, CRNP – University of Maryland Hospital Center |
10:10am | Break | Refreshments in Exhibit Hall |
10:30am | (03) Molecular Testing in Patients with mNSCLC: Applying Concepts Using a Case-Based Review » Michelle Turner, MS, CRNP – Johns Hopkins Sidney Kimmel Comprehensive Cancer Center |
11:30am | Gather Lunch |
11:35am |
Buffet Lunch & Non-CE Symposium Presentation Sponsored by Incyte Corporation: Real-World Case Discussion When To Intervene With Jakafi® (ruxolitinib) In Adults With Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea » Julia King, MSN, RN, ACNP-BC – Virginia Oncology Associates |
12:25pm | Dessert Break in Exhibit Hall |
12:50pm |
(04) Exploring Currently Approved Therapies for Treatment of Early-Stage Breast Cancer » Nelli Zafman, CRNP – Johns Hopkins |
1:50pm | Break | Trivia for Charity in Exhibit Hall |
2:20pm | (05) Healthcare Burnout & Post Covid Treatment Trajectory » Moderator: Rasheda Persinger, MS, AGNP-C, AOCNP » Elizabeth Rauschenberg, CRNP – Maryland Oncology Hematology » Kate Dzintars, PharmD, BCPS – The Johns Hopkins Hospital » Amy Hillsman, CRNP – Reimagine Care, Inc. |
3:20pm | (06) Precision Oncology: Incorporating Cancer Genomics into Patient Care » J Kevin Hicks, PharmD, PhD, FCCP – Moffitt Cancer Center |
4:20pm | Networking Reception |
5:30pm | Dinner Invite sponsored by Regeneron |
Saturday, May 6, 2023 |
7:00am | Check-in & Exhibit Hall Open |
7:10am |
Morning Breakfast Symposium Sponsored by AbbVie: Practical Management of CLL and AML with a BCL-2 Inhibitor » Kelly Valla, PharmD, BCOP |
8:00am | Horizon CME App Overview |
8:05am | Welcome, Introductions, & CE Housekeeping |
8:10am |
(07) Radiation Therapy As A Component of Multidisciplinary Lung Cancer Management » Ravi Chandra, MD, PhD – Mid-Atlantic Permanente Medical Group |
9:10am | (08) Advances in Cancer Drug Therapy: Highlights of New Drugs, Expanding Indications, and Improved Strategies to Optimize Treatment » Michael Singel, PharmD, BCPS, BCOP – The Johns Hopkins Hospital |
10:10am | Break | Refreshments in Exhibit Hall |
10:45am |
(09) Pain Management in Oncology: An Integral Part of Palliative Care » Lissa Ynes Berroa Garcia, MD – Palliative Medicine Consultants |
11:45am | Gather Lunch |
11:50am |
Buffet Lunch & Non-CE Symposium Presentation Sponsored by Pfizer – A First-Line CDK4/6 Inhibitor Combination Therapy: Clinical Trial Evidence Complemented by a Real-World Effectiveness Evaluatio » Ann Oliva, MSN, RN, APRN-CNP – The Ohio State University Wexner Medical Center & OSUCC |
12:40pm | Dessert Break in Exhibit Hall |
1:00pm | (10) CLL: More Interesting Than It Used To Be » Kashif Ali, MD – Maryland Oncology Hematology |
2:00pm | Closing Comments |